Acquisitions, FDA Approvals, Appointments, Language Support Programme, and Event Participations - Analyst Notes on Euronet, Qiagen, Aaron's, Barnes & Noble and HSN

NEW YORK, June 3, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Euronet Worldwide Inc. (NASDAQ: EEFT), Qiagen NV (NASDAQ: QGEN), Aaron's, Inc. (NYSE: AAN), Barnes & Noble, Inc. (NYSE: BKS) and HSN, Inc. (NASDAQ: HSNI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3249-100free.

--
Euronet Worldwide Inc. Analyst Notes
On May 20, 2014, Euronet Worldwide Inc. (Euronet) announced that it has completed the acquisition of HiFX. According to the Company, the acquisition complements Euronet's existing money transfer business, Ria, by expanding its offerings, which include online-initiated, account-to-account international payment, as well as foreign exchange services to high-income individuals and small- to medium-sized businesses. "We are excited to welcome HiFX into the Euronet group of companies," stated Michael J. Brown, Euronet's Chairman and CEO. "Their online presence, affordable rates and deep knowledge of foreign exchange markets, combined with our strong bank relationships, global market entry expertise and solid balance sheet will allow us to expand and improve both Ria's and HiFX's product offerings and increase our market share in a fast-growing sector that produces 9.9 billion payment transactions per year." As per a previous announcement on March 10, 2014, Euronet was in agreement to acquire HiFX for a consideration of c.£145 million or $242 million, which comprises of approximately 1.3 million shares of Euronet stock and c. $185 million in cash. The full analyst notes on Euronet are available to download free of charge at:

http://www.analystsreview.com/Jun-03-2014/EEFT/report.pdf

--
Qiagen NV Analyst Notes
On May 23, 2014, Qiagen NV (Qiagen) announced that it has received FDA approval of therascreen® KRAS RGQ PCR Kit (therascreen KRAS test), which will guide the treatment of metastatic colorectal cancer patients with Amgen's Vectibix® (panitumumab). CEO of Qiagen, Peer M. Schatz remarked, "The U.S. approval of our therascreen KRAS test with Amgen's EGFR inhibitor, Vectibix, marks a further milestone for QIAGEN's global growth in companion diagnostics for personalized healthcare. Our global portfolio covers more than 25 molecular tests targeting various companion diagnostic biomarkers. The performance and ease of use of QIAGEN's tests are now increasingly driving dissemination of personalized healthcare in the U.S. and countries around the world." The full analyst notes on Qiagen are available to download free of charge at:

http://www.analystsreview.com/Jun-03-2014/QGEN/report.pdf

--
Aaron's, Inc. Analyst Notes
On May 21, 2014, Aaron's, Inc. (Aaron's) announced that it has appointed Sharon Lawrence as Vice President of Finance. According to the Company, Ms. Lawrence, who joined the Company in 2012, formerly served as Aaron's Director of Franchise Finance. The Company also announced that Kirby Salgado has joined Aaron's as Vice President of Merchandising. He most recently served as VP/GMM for Sears Holdings and where he held key roles at fred's Super Dollar, Office Depot and Burdines Department Store. The full analyst notes on Aaron's are available to download free of charge at:

http://www.analystsreview.com/Jun-03-2014/AAN/report.pdf

--
Barnes & Noble, Inc. Analyst Notes
On May 22, 2014, Barnes & Noble, Inc. (Barnes & Noble) announced its free June Spanish-language Storytime at select stores across the country. According to the Company, the aforesaid programme will feature a reading of El miedo de Iván (Ivan's Fear) written by Ariel Andres Almada and illustrated by Cha Coco and stories for toddlers, wherein customers can also enjoy word practice and other fun activities. "We are thrilled to have the opportunity to share our favorite Spanish-language books with customers attending our new monthly Spanish-language Storytimes. The June selection, El Miedo de Iván, is an inspiring story about bravery, filled with beautiful illustrations the children will love," said Denise Duarte, Spanish-Language Children's Buyer for Barnes & Noble. The full analyst notes on Barnes & Noble are available to download free of charge at:

http://www.analystsreview.com/Jun-03-2014/BKS/report.pdf

--
HSN, Inc. Analyst Notes
On May 28, 2014, HSN, Inc. (HSN) announced that it will participate in the Goldman Sachs 5th Annual dotCommerce Day in New York City, on Wednesday, June 4, 2014. According to the Company, during the event, HSN's Chief Marketing and Business Development Officer, Bill Brand, and Cornerstone's Senior Vice President of Digital Commerce, Bryon Colby will be meeting with investors. The full analyst notes on HSN are available to download free of charge at:

http://www.analystsreview.com/Jun-03-2014/HSNI/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED